XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities    
Net loss $ (79,275) $ (249,053)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 59,877 85,364
Stock-based compensation 11,194 44,112
Impairment of goodwill 0 115,483
Impairment of assets held for sale 0 3,276
Amortization of debt issuance costs 2,966 4,663
Noncash lease expense 1,407 1,327
Change in fair value of warrant liabilities (1,471) (6,873)
Deferred tax benefits (1,581) (19,385)
(Gain) loss from debt extinguishment (20,109) 619
Share-based compensation liabilities 15,765 0
Other, net (27) 1,750
Changes in operating assets and liabilities:    
Accounts receivable (1,487) 17,786
Prepaid expenses and other current assets 2,437 647
Accounts payable (75) 5,223
Accrued expenses and other current liabilities 5,671 (71)
Deferred revenue (91) 12,746
Long-term earnout liabilities 0 (20,000)
Other non-current liabilities (1,228) (3,522)
Net cash used in operating activities (6,027) (5,908)
Cash Flows from Investing Activities    
Purchases of property and equipment (31) (2,015)
Capitalized software development costs (4,931) (4,844)
Net cash used in investing activities (4,962) (6,859)
Cash Flows from Financing Activities    
Proceeds from related-party loan, net of lender fees 0 63,000
Repayments of related party loan, inclusive of lender fees 0 (44,000)
Repayment of Term Loan (56,786) (15,000)
Payment of acquisition holdback 0 (1,935)
Taxes paid related to net settlement of stock awards (2,137) (3,053)
Distributions to members, net of contributions (27) (66)
Net cash used in financing activities (58,950) (1,054)
Effect of exchange rate changes in cash, cash equivalents and restricted cash 81 (231)
Net decrease in cash, cash equivalents and restricted cash (69,858) (14,052)
Cash and cash equivalents and restricted cash, beginning of the period 143,450 39,075
Cash and cash equivalents and restricted cash, end of the period 73,592 25,023
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 69,092 4,853
Restricted cash 4,500 7,779
Cash and restricted cash included in assets held for sale from discontinued operations 0 12,391
Total cash, cash equivalents and restricted cash 73,592 25,023
Supplemental cash flow information:    
Capitalized assets financed by accounts payable 0 53
Stock-based compensation included in capitalized software development costs 1,113 1,644
Settlement of incentive plan through issuance of common stock $ 1,707 $ 1,658